Eli Lilly Launches Multi-Dose Zepbound Pen to Drive Obesity Drug Growth
Eli Lilly unveiled a new multi-dose version of its blockbuster obesity drug Zepbound, allowing patients to receive a full month of doses in a single injection.
Anthropic's record-breaking IPO has Wall Street buzzing! GraniteShares CEO Will Rhind unpacks the AI stock frenzy, soaring valuations and bubble fears.
Robots are roaming grocery aisles! Simbe's Caitlin Allen joins us to unpack how AI-powered machines are changing shopping, stocking shelves and retail jobs.